The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 29, 2019

Filed:

Sep. 03, 2014
Applicants:

Affichem, Toulouse, FR;

Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;

Inventors:

Philippe de Medina, Toulouse, FR;

Michael Paillasse, Toulouse, FR;

Christian Recher, Toulouse, FR;

Marc Poirot, Toulouse, FR;

Sandrine Silvente Poirot, Toulouse, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/58 (2006.01); A61K 31/575 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2006.01); A61K 33/36 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/58 (2013.01); A61K 31/575 (2013.01); A61K 31/704 (2013.01); A61K 33/24 (2013.01); A61K 33/36 (2013.01); A61K 45/06 (2013.01);
Abstract

Dendrogenin A and antineoplastic agents for the treatment of chemosensitive or chemoresistant tumors. The invention concerns a kit-of-parts comprising 5α-hydroxy-6β-[2-(1H-imidazol-4-yl)ethylamino]cholestan-3β-ol (Dendrogenin A) or a pharmaceutically acceptable salt thereof and an antineoplastic agent for use in the treatment of cancer. Furthermore, the invention concerns Dendrogenin A or a pharmaceutically acceptable salt thereof for use for treating a chemoresistant cancer.


Find Patent Forward Citations

Loading…